Skip to content

DCVC Opportunity Fund II GP, LLC

Follow

13F filer, CIK 1668343, Palo Alto, CA

DCVC Opportunity Fund II GP, LLC reported $18,542,133 across 2 holdings for the quarter ended 2026-09-30, in a 13F-HR filed 2026-11-16.

Accepted , ingested 13F-HR 0001104659-26-128237

Period
2026-09-30
Reported value
$18.5M
Holdings
2
Top 10 weight
100%
New
0
Sold out
0

Holdings, Q3 2026

Share positions as resolved from 13F-HR 0001104659-26-128237, largest first. % of portfolio is the value over $18,542,133, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
RXRXRECURSION PHARMACEUTICALS INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 3,951,141 shares; 2025Q1: 3,951,141 shares; 2025Q2: 3,951,141 shares; 2025Q3: 3,951,141 shares; 2025Q4: 3,951,141 shares; 2026Q1: 3,951,141 shares; 2026Q2: 3,951,141 shares; 2026Q3: 3,951,141 shares 3,951,141$16.3M88.01%0Timeline
IONQIONQ INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 9,521 shares; 2026Q1: 60,226 shares; 2026Q2: 50,705 shares; 2026Q3: 50,705 shares 50,705$2.22M11.99%0Timeline

How Q3 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001104659-26-128237 base2026-11-16